Young Alison Luk, McEnallay Melissa, Day Fiona, Vinod Shalini K, Stone Emily, Morris Sarah, Stefanovska Elena, Devitt Bianca, Yip Po Yee, Kukard Craig, Pal Abhijit, Thawal Vaibhav, Wright Gavin, Hofman Alison, Sareen Heena, McLennan James, Wong Shuet Oi, Rubio Cassandra, Liu Jennifer, Smith Alexandra, Betts Dimity, Mack Jane, Donnelly Jennifer, Barker Daniel, Paul Christine
School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.
Department of Medical Oncology, Calvary Mater Newcastle, Waratah, Australia.
Asia Pac J Clin Oncol. 2025 Aug;21(4):368-376. doi: 10.1111/ajco.14153. Epub 2025 Feb 1.
Smoking is a chronic relapsing condition that is under-reported in oncology settings. People who report current smoking (CS) and those who report recently quitting smoking (RQ) should receive cessation support when they are diagnosed with cancer. The study aimed to identify whether differences exist in the smoking cessation support given to CS and RQ in oncology and what advice is given regarding the benefits of cessation.
A survey exploring smoking cessation practices was completed by oncology clinicians (medical, nursing, and allied health) at nine cancer centers in Australia. Data were analyzed using mixed-effects ordinal regression modeling.
Across the 177 clinicians completing the survey, the reported provision of smoking cessation care was significantly higher for CS than for RQ in relation to asking about smoking status (odds ratio [OR] 3.03, p = 0.001), advice on the benefits of quitting (OR 2.86, p = 0.001), and advice to call the Quitline (OR 5.08, p < 0.001). Exploratory analyses indicated doctors and nurse specialists were four times more likely to report referring CS to a Quitline compared to RQ (OR 4.38, p = 0.001; OR 4.29, 95%, p = 0.005, respectively). The cessation benefits that clinicians most often cited to their patients was that quitting "can reduce the chance of developing treatment complications and side effects".
The relative lack of smoking cessation care provided to RQ in oncology suggests that the high risk of smoking relapse is not well-recognized. Greater awareness and training are needed regarding advising RQ about the survival-specific benefits of continuing to not smoke, offering referrals, and offering follow-up support.
吸烟是一种慢性复发性疾病，在肿瘤学环境中报告不足。报告当前吸烟（CS）的人和报告最近戒烟（RQ）的人在被诊断患有癌症时应获得戒烟支持。该研究旨在确定肿瘤学中给予CS和RQ的戒烟支持是否存在差异，以及就戒烟的益处给出了哪些建议。
澳大利亚九个癌症中心的肿瘤学临床医生（医学、护理和专职医疗人员）完成了一项关于戒烟实践的调查。使用混合效应有序回归模型分析数据。
在完成调查的177名临床医生中，在询问吸烟状况（优势比[OR] 3.03，p = 0.001）、关于戒烟益处的建议（OR 2.86，p = 0.001）以及拨打戒烟热线的建议（OR 5.08，p < 0.001）方面，报告为CS提供的戒烟护理显著高于RQ。探索性分析表明，与RQ相比，医生和护士专家报告将CS转介到戒烟热线的可能性高出四倍（分别为OR 4.38，p = 0.001；OR 4.29，95%，p = 0.005）。临床医生最常向患者提及的戒烟益处是戒烟“可以降低出现治疗并发症和副作用的几率”。
肿瘤学中给予RQ的戒烟护理相对不足，这表明吸烟复发的高风险未得到充分认识。在向RQ告知持续不吸烟对生存的特定益处、提供转介服务以及提供后续支持方面，需要提高认识并进行培训。
